NANOMETRIX LTD

NANOMETRIX LTD specializes in advanced extracellular vesicle analysis for biomedical research and clinical diagnostics, leveraging cutting-edge single-vesicle characterization technologies. Their core capabilities center on high-resolution isolation, quantification, and molecular profiling of extracellular vesicles from complex biological samples, particularly those derived from human participants in longitudinal health studies. The company applies precision analytical methods such as nanoparticle tracking analysis, flow cytometry, and biomarker detection to extract actionable biological insights from minute biofluid volumes. Their technical expertise includes sample handling protocols for fragile vesicle populations, data-driven interpretation of vesicular cargo, and integration of analytical workflows compliant with clinical research standards. NANOMETRIX distinguishes itself through its focus on reproducible, low-volume, participant-specific vesicle profiling—an emerging niche critical to personalized medicine and early disease detection. The contractor has demonstrated direct engagement with the Department of Health and Human Services, delivering specialized laboratory services focused on biomarker discovery and participant-derived biological analysis. This relationship underscores a targeted alignment with HHS-funded research initiatives involving precision health, population studies, and translational biomedical programs. NANOMETRIX operates primarily within the Testing Laboratories and Services sector (NAICS 541380), positioning itself at the intersection of clinical diagnostics and molecular biology. Their market focus is on translational research services that bridge laboratory innovation with real-world health data, serving the growing demand for exosome and microvesicle-based biomarkers in oncology, neurology, and immunology applications. As a small business structured under the 2L entity classification, NANOMETRIX LTD is headquartered in Oxford with no federal certifications on record. The company maintains a focused, research-driven presence in the federal biomedical contracting space, emphasizing technical rigor over scale. Their geographic footprint is localized, but their analytical capabilities are designed for national research networks requiring high-fidelity biological data.